Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Platinum Compounds × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 32 Lung Neoplasms 6 Ovarian Neoplasms 5 Esophageal Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Neoplasms 2 Neoplasm Metastasis 2 Urinary Bladder Neoplasms 1 Squamous-Cell Lung Cancer 1 Retinoblastoma 1 Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC) 1 Resectable Non-small Cell Lung Cancer 1 Resectable Lung Non-Small Cell Carcinoma 1 Recurrence 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Ovarian Cancer Recurrent 1 Oropharyngeal Neoplasms 1 Nonsquamous Non-small Cell Lung Cancer 1 NSCLC 1 Melanoma 1 Liver Neoplasms 1 Head and Neck Neoplasms 1 Glioma 1 Gallbladder Neoplasms 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1

Interventions

Cyclophosphamide 133 Dexamethasone 107 Rituximab 70 fludarabine 65 Lenalidomide 59 Cytarabine 59 Gemcitabine 54 fludarabine phosphate 49 Bortezomib 48 pembrolizumab 46 venetoclax 45 Etoposide 44 Paclitaxel 43 Carboplatin 42 Cisplatin 41 pomalidomide 39 Peripheral Blood Stem Cell Transplantation 38 Filgrastim 37 Radiotherapy 35 Bevacizumab 33 Melphalan 31 Busulfan 31 Calcium Dobesilate 29 carfilzomib 28 Cyclosporine 28 Methotrexate 27 Azacitidine 26 Nivolumab 25 Mycophenolic Acid 25 Temozolomide 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07340164 2026-01-14

TROY

Yonsei University

Phase 2 Not yet recruiting

Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡